Intra-Cellular Therapies: Q3 Earnings Insights

Intra-Cellular Therapies ITCI reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Intra-Cellular Therapies their estimated earnings by 3.26%, reporting an EPS of $-0.95 versus an estimate of $-0.92, which did not surprise analysts.

Revenue was up $14,838,000 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.05, which was followed by a 8.8% drop in the share price the next day.

Here's a look at Intra-Cellular Therapies's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.